1. Hepatocellualar Carcinoma Serum Markers
   Gaetano Bertino et al, 2012, Seminars in Oncology CrossRef
2. A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment
   Masaya Saito et al, 2012, Journal of Gastroenterology CrossRef
3. Tumor Stroma, Desmoplasia, and Stromagenesis
   Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
4. Development and validation of a modified albumin–bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab
   Takeshi Hatanaka et al, 2023, Hepatology International CrossRef
5. Vascular Endothelial Growth Factor Level as A Predictor of Hepatocellular Carcinoma in Liver Cirrhosis Patients
   Benyamin Lukito et al, 2014, The Indonesian Biomedical Journal CrossRef
6. Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma
   Gabriele Ricco et al, 2020, Cancer Biomarkers CrossRef
7. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des‐γ‐carboxyprothrombin
   Yoshinori Inagaki et al, 2011, Liver International CrossRef
8. Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
   Munechika Enjoji et al, 2015, Diseases CrossRef
9. NX-DCP as a novel biomarker would be related to liver function in cirrhotic patients with hepatocellular carcinoma
   Hirotaka Hirano et al, 2013, European Journal of Gastroenterology & Hepatology CrossRef
10. Enhanced Antitumor Effects of Novel Intracellular Delivery of an Active Form of Menaquinone-4, Menahydroquinone-4, into Hepatocellular Carcinoma
    Shuichi Setoguchi et al, 2015, Cancer Prevention Research CrossRef
11. Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma
    Tatsuya Taniguchi et al, 2017, Digestion CrossRef
12. Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma
    Teiji Kuzuya et al, 2022, Oncology CrossRef
13. Antitumor Effects and Delivery Profiles of Menahydroquinone-4 Prodrugs with Ionic or Nonionic Promoiety to Hepatocellular Carcinoma Cells
    Shuichi Setoguchi et al, 2018, Molecules CrossRef
14. An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib
    Dong-Hwan Jung et al, 2015, Korean Journal of Hepato-Biliary-Pancreatic Surgery CrossRef
15. Des-γ-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma
    Akiko Sumi et al, 2015, PLOS ONE CrossRef
16. Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
    Takahide Nakazawa et al, 2013, European Journal of Gastroenterology & Hepatology CrossRef
17. Predictors of Microvascular Invasion in Hepatocellular Carcinoma
    Yo-ichi Yamashita et al, 2015, Digestive Diseases CrossRef
18. Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma
    Hideto Suzuki et al, 2011, Journal of Gastroenterology CrossRef
19. Tumor Stroma, Desmoplasia, and Stromagenesis
    Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
20. Association of des-γ-carboxy prothrombin production and Sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades
    Kazumoto Murata et al, 2018, Journal of Medical Ultrasonics CrossRef
21. Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments
    Yo‐ichi Yamashita et al, 2018, Annals of Gastroenterological Surgery CrossRef
22. Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
    Yoshinari Asaoka et al, 2014, PLoS ONE CrossRef
23. Atrazine represses S100A4 gene expression and TPA-induced motility in HepG2 cells
    Ludovic Peyre et al, 2014, Toxicology in Vitro CrossRef
24. Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib
    Kenichiro Kodama et al, 2019, Oncology CrossRef
25. Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma
    Masatoshi Kudo, 2024, Liver Cancer CrossRef
26. Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection
    Rumi Matono et al, 2012, HPB CrossRef